相关实验视频

Updated: Jul 19, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

关于ACADVL变体解释ACMG/AMP指南的规范

May Flowers¹, Alexa Dickson², Marcus J Miller³

¹Invitae Corporation, San Francisco, CA 94103, USA.

Molecular genetics and metabolism

|August 7, 2023

概括

非常长链乙-CoA脱酶缺乏症 (VLCADD) 需要基因检测,因为不特定的症状. 成立了一个专家小组,以标准化ACADVL变体分类,以改善这种代谢障碍的诊断.

科学领域:

生物化学生化学
遗传学是一个遗传学.
代谢障碍代谢障碍代谢障碍

背景情况:

非常长链乙-CoA脱酶缺乏症 (VLCADD) 是一种常见的遗传代谢障碍.
正确的诊断是具有挑战性的,因为非特异性的表型和晚发的可能性.
通过ACADVL基因测序进行分子确认对于预测受影响状态至关重要.

研究的目的:

为了解决ACADVL变异的不同分类问题.
为VLCADD变体解释建立标准化指南.
提高诊断准确度和简化变种分类.

主要方法:

形成一个ACADVL特定的变异治疗专家小组 (VCEP).
对VLCADD的ACMG/AMP指南的规范.
对ACADVL基因变异的审查和分类.

主要成果:

为ACADVL变种制定了标准化分类指南.
该VCEP旨在提高变体解释的一致性.
期待加快和更一致的变种分类.

结论:

建立了一个专门的VCEP来完善VLCADD的变种分类.
预计新的指导方针将提高诊断一致性.
简化分类将加速VLCADD的诊断.

关键词:

ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL ACADVL 在ClinGen中,使用ClinGen.致病性致病性致病性变体解释的变体解释

更多相关视频

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

相关概念视频

Estimation of k and VD of Aminoglycosides

Estimation of k and V_D of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...